Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10464992
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 10457725
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
US 10442864
Anti-Tie2 antibodies and uses thereof
granted -
US 10442856
Methods of treating obesity with anti-ANGPTL8 antibodies
granted -
US 10435473
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 10426848
Humanized FcγR mice
granted -
US 10428135
Fusion polypeptides capable of activating receptors
granted -
US 10428157
Dosing regimens for use with PCSK9 inhibitors
granted -
US 10426146
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 10421804
Anti-Zika virus antibodies and methods of use
granted -
US 10406226
Method of manufacturing VEGF antagonist fusion proteins
granted -
US 10406222
Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein
granted -
US 10400036
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
granted -
US 10400025
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 10392430
Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 10392432
Human antibodies to influenza hemagglutinin
granted -
US 10390522
Non-human animals having a humanized programmed cell death 1 gene
granted -
US 10392439
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
granted -
US 10377817
Human antibodies to GREM1
granted -
US 10370449
Methods for treating skin infection by administering an IL-4R antagonist
granted -
US 10358495
Anti-LAG3 antibodies and uses thereof
granted -
US 10358487
Anti-ANGPTL3 antibodies and uses thereof
granted -
US 10342876
Process for reducing subvisible particles in a pharmaceutical formulation
granted -
US 10316105
Anti-TIE2 antibodies and uses thereof
granted